8 - INSULIN (LR 11.1.18) - FLAME · 2019-04-21 · INDICATIONS FOR INSULIN u Type 1 Diabetes u Type...
Transcript of 8 - INSULIN (LR 11.1.18) - FLAME · 2019-04-21 · INDICATIONS FOR INSULIN u Type 1 Diabetes u Type...
LEARNING OBJECTIVESu To understand Insulin use in diabetes u To describe indications, mechanism of action, and
side effects of InsulinuPrerequisites: None uSee also – for closely related topics
uFLAMEs on Type 2 DM / Medications for treatment of DM
INDICATIONS FOR INSULIN u Type 1 Diabetesu Type 2 Diabetes
u If lifestyle changes and oral therapy are not adequate for glycemic control u Can add to oral therapy if A1c remains >8.5% u Initial therapy if presenting A1c >9.0%
u If insulin monotherapy, usually use basal insulin
u All patient with end stage renal disease
u Gestational diabetesu Acute hyperkalemia
MECHANISM OF ACTIONu Lowers blood glucose levels by promoting absorption from blood and
into storage u Storage in liver, skeletal muscle, and adipose tissue
u Carbohydrates: u Increases: uptake of glucose into cell, increase glycogenesis and glycolysisu Decreases: glycogenolysis and gluconeogenesis
u Lipids: u Increases: lipid synthesisu Decreases: lipolysis and ketogenesis
u Proteins: u Increase: protein synthesis and uptake of amino acids u Decreases: proteolysis
u Other: u Increase: K uptake, cell growth, secretion of gastric acid
PHARMACOKINETICSu Rapid-acting insulin: Lispro/Aspart= “meal-time insulin”
u Onset: 15-30 minu Peak: 30 min-1.5 hru Duration: 3-5 hr
u Short-acting insulin: Regular insulinu Onset: 30 min-1hru Peak: 2-4 hru Duration: 5-8 hr
u Intermediate-acting insulin: NPH insulin (usually BID administration) u Onset: 1-2 hru Peak: 4-12 hru Duration 14-24 hr
PHARMACOKINETICS (CONT)u Long-acting insulin: Glargine/Detemir (once a day or BID)
u Detemir: u Onset: 3-4 hr
u Peak 6-8 hr
u Duration: 6-23 hr
u Glargineu Onset: 1.5 hr
u Peak: None
u Duration: 24 hr
u Mixed insulin = mix of regular and NPH (ex: 70/30) (BID or TID)u Onset: 15-60 min u Duration: 14-24 hr
DOSING
u 0.3-0.6 U/kg/dayu 50% basalu 50% bolus
u 1/3 breakfast
u 1/3 lunch
u 1/3 dinner
u Ex: Patient weighs 120 kg à 120 x 0.6= 72 Uu 36 U basal
u 36 U bolusu 12 U at each breakfast, lunch, and dinner
u If initiating basal only: usually 0.2 U/kg w/ of minimum 10 U
MORE TO KNOW ABOUT DOSING
u Insulin Sensitivity: how much 1U of insulin is expected to decrease the blood glucose level u When blood glucose above pre-defined goal, short-acting
insulin is added to the normal bolus dose or given separately between meals
u Calculation: 1800/total daily insulin requirement u On average, 1U will lower serum glucose by 25 mg/dL
u Correcting for carbohydrates: # of units of insulin needed to cover for # of grams of carbohydrates ingestedu Calculation: 500/total daily insulinu On average, about 1 unit/10 g carb
MORE TO KNOW ABOUT DOSING
uSliding Scale: checking blood glucose level and dosing insulin based on the value
BLOOD SUGAR (mg/dL)
INSULIN DOSE (Units of rapid
or short-acting)<150 0150-200 2201-250 4251-300 6301-350 8351-400 10401-450 12>450 14
DOSE TITRATIONu Fasting glucose values used to titrate basal
u Usually titrate 2-4U every 3-7 days until at goal u Pre-prandial and post-prandial values used to titrate
bolus/meal-timeu Increase/decrease by approx 10% based on home readings
u Can do this every 3-7 days until at goal u Titrate based on the following goals
u Fasting: 90-130 u Postprandial: <180 u A1c: <7.0
u Should have patient follow up at least every 3 months for insulin review/management
SIDE EFFECTSu Hypoglycemia
u More common in premixed and bolus
u Weight gainu More common with large bolus (“meal-time”) regimens
u Lidodystrophy at injection siteu Pain and erythema of injection siteu Hypokalemiau Allergic reaction (rare)u Edema (rare)